| Name | Title | Contact Details |
|---|
Since 2001, Regent Surgical Health has led the way in developing and managing successful surgery center partnerships. The ASC model is constantly evolving and Regent positions our facility partners to meet these changing market conditions and succeed. Today, a vast majority of our partnerships are Physician/Hospital Joint Ventures. Our experience has led us to develop proprietary ownership models that give both doctors and hospital administrators what they need to ensure long term clinical and financial success. Our success had earned us a reputation as Joint Venture Specialists. Regent has extensive knowledge of the ASC marketplace. We have found successful financial solutions to increase net revenues rather than using out of network strategies, pioneered new procedures such as spine, cardiology, gastric banding, and knee replacements into the ASC environment, and developed both majority and minority hospital partnerships. At Regent, our track record for successful ASC Turnarounds, De Novos, and Joint Ventures is unmatched.
Volition is a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. Early diagnosis and monitoring have the potential to not only prolong the life of patients but also improve their quality of life. The tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring. Volition`s research and development activities are centered in Belgium, with an innovation laboratory in California and additional offices in Texas, London, and Singapore, as the company focuses on bringing its diagnostic and disease monitoring products to market.
Hooper Holmes is a data-driven leader in collecting personal health data and transforming it into useful information, which in turn, enables our customers to take actions that manage or reduce their risks and expenses. As the foremost provider of risk assessment services for the insurance industry, we are the only company that can provide insurers with ALL the services they need to reach their ultimate goal: complete policy medical exam, data collection, laboratory testing, inspection reports and underwriting services in the industry. Each year we arrange more medical exams than any other company and process millions of specimens in our laboratory. And we provide a complete service for wellness, disease management, and managed care companies including scheduling support, fulfillment of supplies, blood collection kits, medical screenings, lab testing and data transmission.
digiChart Announces New Executives and New Offices July 15, 2010 BRENTWOOD, Tenn.--(BUSINESS WIRE)--digiChart, Inc. today announced the appointment of two new members to its executive team, Bob Allen and Stephen Faris. The company also announced the relocation of its headquarters to Brentwood, TN, a nearby suburb of Nashville, TN. Bob Allen joins digiChart as National Director of Sales. Mr. Allen will be responsible for all the sales and marketing efforts of the company. Most recently, he served as Vice President of Sales in McKessons Physician Practice Solutions business. He brings over 20 years experience in sales and healthcare technology. Stephen Faris will serve as Vice President of Technology, leading digiCharts product development and technical operations. He previously served as Chief Technology Officer for Healthgate Data Corporation and has extensive experience consulting with companies on their technology and applications strategies. We are excited two exceptional leaders such as Bob and Stephen join our executive team, said digiChart CEO Bill Bates. We are growing and moving forward with exciting initiatives to fully connect OB-GYN care. Bob and Stephens experience will serve us well. They will be central to our success. digiChart also announced the relocation of its headquarters to Brentwood, TN, a nearby suburb of Nashville, TN. The move positions the leader in OB-GYN electronic medical records and practice management systems software for its growth plans and will enable improved service and support for its customers throughout the United States. The Nashville area is a hub for the healthcare, said COO Shelley Predmore. We have enjoyed a rewarding history of growth and success from being in the center of the industrys activities and will continue to do so. Our new offices offer us a state-of-the-art training center for our clients and better consolidate our overall operations. The space will serve us for years to come as we serve our customers. The companys new address is: digiChart, Inc. 100 Winner's Circle, Suite 450 Brentwood, TN 37027 About digiChart, Inc. (www.digichart.com) Based in Brentwood, TN, digiChart, Inc. is a leader in healthcare information technology solutions and services. Dedicated to improving women's healthcare, digiChart provides electronic health record (EHR) and practice management system (PMS) solutions, along with the related training, implementation and workflow improvement services. OB-GYN practices across the country use digiChart's solutions to streamline and optimize their practices clinically and inancially, as well as achieve higher rates of patient satisfaction. Every day, over 100,000 active pregnancies and nearly 1,800,000 womens records are managed through digiCharts solutions. digiChart is a MedCare company. MedCare is a althcare-focused fund invested in a portfolio of healthcare services, healthcare IT and medical device companies with combined revenues of over $350M. Contacts digiChart, Inc. Shelley Predmore, Chief Operating Officer, 615-312-1630 ore@digichart.com
Terra Nova Transcription is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.